|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
230,290,000 |
Market
Cap: |
138.17(K) |
Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,994 |
52
Week Range: |
$0.0001 - $0.055 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lazar Michael B |
10% Owner |
|
2004-10-22 |
4 |
OE |
$3.42 |
$142,983 |
I/I |
41,808 |
59,658,341 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2004-10-20 |
4 |
OE |
$3.42 |
$171,000 |
D/D |
50,000 |
71,348,988 |
|
- |
|
Loverro Frank J |
Director |
|
2004-10-20 |
4 |
OE |
$3.42 |
$131,882 |
I/I |
38,562 |
55,028,079 |
|
- |
|
Loverro Frank J |
Director |
|
2004-10-20 |
4 |
OE |
$3.42 |
$142,983 |
I/I |
41,808 |
59,658,341 |
|
- |
|
Lazar Michael B |
10% Owner |
|
2004-10-20 |
4 |
OE |
$3.42 |
$142,983 |
I/I |
41,808 |
59,658,341 |
|
- |
|
Lazar Michael B |
10% Owner |
|
2004-10-20 |
4 |
OE |
$3.42 |
$131,882 |
I/I |
38,562 |
55,028,079 |
|
- |
|
Loverro Frank J |
Director |
|
2004-08-09 |
4 |
OE |
$2.42 |
$7,237,043 |
I/I |
2,966,247 |
55,066,642 |
|
- |
|
Loverro Frank J |
Director |
|
2004-08-09 |
4 |
S |
$17.46 |
$93,917,462 |
I/I |
(5,379,007) |
58,032,889 |
|
- |
|
Loverro Frank J |
Director |
|
2004-08-09 |
4 |
OE |
$2.42 |
$7,845,995 |
I/I |
3,215,838 |
59,700,148 |
|
- |
|
Loverro Frank J |
Director |
|
2004-08-09 |
4 |
S |
$17.46 |
$101,820,015 |
I/I |
(5,831,616) |
62,915,986 |
|
- |
|
Lee David A H |
Exec. V.P and CSO |
|
2004-08-09 |
4 |
S |
$17.46 |
$8,685,564 |
D/D |
(497,455) |
0 |
|
- |
|
Lee David A H |
Exec. V.P and CSO |
|
2004-08-09 |
4 |
OE |
$2.42 |
$1,203,841 |
D/D |
497,455 |
497,455 |
|
- |
|
Kimmel Roger H |
Director |
|
2004-08-09 |
4 |
S |
$17.46 |
$640,206 |
I/I |
(36,667) |
454,526 |
|
- |
|
Wahrhaftig David I |
Director |
|
2004-08-09 |
4 |
OE |
$2.42 |
$7,237,043 |
I/I |
2,966,247 |
55,066,642 |
|
- |
|
Wahrhaftig David I |
Director |
|
2004-08-09 |
4 |
S |
$17.46 |
$93,917,462 |
I/I |
(5,379,007) |
58,032,889 |
|
- |
|
Hyatt Michael |
Director |
|
2004-08-09 |
4 |
S |
$17.46 |
$320,094 |
I/I |
(18,333) |
152,999 |
|
- |
|
Hyatt Michael |
Director |
|
2004-08-09 |
4 |
S |
$17.46 |
$640,206 |
D/D |
(36,667) |
592,884 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2004-08-09 |
4 |
OE |
$2.42 |
$9,383,494 |
D/D |
3,846,013 |
71,398,988 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2004-08-09 |
4 |
S |
$17.46 |
$121,772,657 |
D/D |
(6,974,379) |
75,245,001 |
|
- |
|
Ammon Carol A |
Chairman and CEO |
|
2004-08-09 |
4 |
S |
$17.46 |
$23,202,192 |
D/D |
(1,328,877) |
0 |
|
- |
|
Ammon Carol A |
Chairman and CEO |
|
2004-08-09 |
4 |
OE |
$2.42 |
$3,215,882 |
D/D |
1,328,877 |
1,328,877 |
|
- |
|
Wahrhaftig David I |
Director |
|
2004-08-09 |
4 |
OE |
$2.42 |
$7,845,995 |
I/I |
3,215,838 |
59,700,148 |
|
- |
|
Wahrhaftig David I |
Director |
|
2004-08-09 |
4 |
S |
$17.46 |
$101,820,015 |
I/I |
(5,831,616) |
62,915,986 |
|
- |
|
Manogue Caroline B |
Exec. V.P., CLO & Secy |
|
2004-08-09 |
4 |
S |
$17.46 |
$553,884 |
D/D |
(31,723) |
0 |
|
- |
|
Manogue Caroline B |
Exec. V.P., CLO & Secy |
|
2004-08-09 |
4 |
OE |
$2.42 |
$80,864 |
D/D |
31,723 |
31,723 |
|
- |
|
825 Records found
|
|
Page 30 of 33 |
|
|